SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
Shan Zhang,Yujia Lu,Wei Shi,Yi Ren,Kaihui Xiao,Wei Chen,Li Li,Jingjie Zhao
DOI: https://doi.org/10.2147/DDDT.S370825
2022-08-24
Abstract:Shan Zhang, 1 Yujia Lu, 1 Wei Shi, 1 Yi Ren, 1 Kaihui Xiao, 1 Wei Chen, 2 Li Li, 1 Jingjie Zhao 1, 3 1 Department of Traditional Chinese Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China; 2 Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China; 3 Department of Integrated Traditional and Western Medicine, Capital Medical University, Beijing, 100050, People's Republic of China Correspondence: Jingjie Zhao, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong-an Road, Beijing, 100050, People's Republic of China, Tel/Fax +86 10-63139096, Email Objective: Chaihu Shugan San (CSS) has a long history for treating major depressive disorder (MDD), which has been verified effectively and safely in clinical studies. Deficient angiogenesis plays important roles in MDD. However, the underlying mechanisms of CSS on angiogenesis remain poorly understood. Methods: Network pharmacology analysis was applied to explore the potential angiogenic targets and pathways between CSS and MDD. These targets would be validated in chronic unpredictable mild stress (CUMS)-induced depressive-like mice by Western blots, immunofluorescence, and immunohistochemistry. Then, the underlying molecular mechanisms were further investigated in brain microvascular endothelial cells (BMVECs) with CSS-containing serum by Western blots and immunofluorescence. Results: Network pharmacology analysis showed that the antidepressant role of CSS was closely associated with Silent information regulator protein 1 (SIRT1)/Forkhead box O1 (FOXO1) axis-mediated angiogenesis. This prediction was confirmed in the following experiments. CSS induced angiogenesis, increased SIRT1 expression, and decreased FOXO1 expression in the hippocampus of CUMS mice. Five percent CSS-containing serum produced a significant increase in BMVECs proliferation, migration, and tube formation, but these effects were reduced by SIRT1 silencing. CSS serum could also promote FOXO1 translocation to the cytoplasm through SIRT1 signaling, which triggered FOXO1 protein degradation. What is more, CSS upregulated VEGFA and BDNF expressions not only in the hippocampus of depressive mice but also in BMVECs supernatants. Of note, these trophic factors play important roles in promoting neurogenesis. Conclusion: The study showed that CSS could promote angiogenesis and neurogenesis in the hippocampus of CUMS-induced mice. The underlying molecular mechanism involves the SIRT1/FOXO1 axis and subsequent regulation of VEGFA and BDNF. These findings provide novel insight into CSS drug development, and targeting the SIRT1/FOXO1 axis might be a promising strategy to treat MDD. Graphical Keywords: major depressive disorder, Chaihu Shugan San, SIRT1/FOXO1 axis, angiogenesis, brain microvascular endothelial cell Graphical Major depressive disorder (MDD) is a serious mental disorder, characterized by a high incidence, diverse symptoms, complex etiologies, and unclear pathological mechanisms. 1 In currently clinical practice, traditional antidepressants were not effective to all patients; only 40–60% of patients respond to antidepressant therapy, among which approximately one third achieve remission and 30% may occur treatment resistance although receiving optimal antidepressant treatment according to consensus guidelines. 2 Furthermore, these antidepressants usually cause some side effects including gastrointestinal side effects, blurred vision, sexual problems, etc. 3,4 Compared with traditional antidepressant drugs, the antidepressant effect of ketamine is obvious and quick. However, ketamine does not present an ideal profile as an antidepressant due to its potential psychotomimetic effects as well as abuse potential. 5,6 Besides, other antidepressant treatments such as psychotherapy and repetitive transcranial magnetic stimulation (rTMS) also have a certain curative effect but they also have some adverse effects or limitations. For example, the most common adverse effects for rTMS are scalp pain during stimulation (∼40%) and transient headache after stimulation (∼30%). 7 Psychotherapy, relatively non-invasive to patients, is recommended to treat mild depression. 8 Therefore, there is a constant need to develop novel antidepressants with greater efficacy, fewer side effects for MDD treatment, which has become a focus of research in recent years. Chaihu Shugan San (CSS) is a classical traditional Chinese medicine (TCM) formula that is used c -Abstract Truncated-